Gabriela Toro Cabrera

Title: Gabriela Toro Cabrera: Innovator in Genetic Therapeutics

Introduction

Gabriela Toro Cabrera is a prominent inventor based in Worcester, MA (US). She has made significant contributions to the field of genetic therapeutics, particularly in the treatment of hereditary sensory and autonomic neuropathy 1 (HSAN1). Her innovative work has the potential to impact many lives.

Latest Patents

Gabriela holds a patent for her invention titled "Modulation of SPTLC1 via recombinant adeno-associated vectors." This patent describes compositions, including isolated nucleic acids and recombinant adeno-associated vectors (rAAVs), that comprise a transgene encoding an inhibitory nucleic acid. This invention aims to decrease the expression of the gene encoding the serine palmitoyltransferase protein, specifically SPTLC1. The methods outlined in her patent provide a promising approach to treating HSAN1 by administering these compositions to affected cells or subjects.

Career Highlights

Gabriela is affiliated with the University of Massachusetts, where she continues her research and development in genetic therapies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Gabriela collaborates with esteemed colleagues, including Christian Mueller and Robert H Brown, Jr. These partnerships enhance her research efforts and contribute to the advancement of her projects.

Conclusion

Gabriela Toro Cabrera is a trailblazer in the field of genetic therapeutics, with a focus on innovative treatments for hereditary conditions. Her contributions through her patent and collaborations reflect her dedication to improving healthcare solutions.